Mesothelioma Trials: Gemcitabine and Cisplatin
Please note: This 2009 clinical trial profile is provided for informational purposes only. In order to obtain more details about this trial, contact the participating healthcare facilities listed at the bottom of this page.
If you are looking for an attorney because you or a loved one has been diagnosed with mesothelioma, asbestos-related lung cancer or asbestosis, our law firm can help. Please fill out the form on this page for a FREE review of your asbestos case.
The Dana Farber Cancer Institute in Boson, Massachusetts is currently seeking individuals who have been diagnosed with mesothelioma to participate in clinical trials. This Phase I study is designed to evaluate the effectiveness of combination chemotherapy by administering Gemcitabine and Cisplatin in a surgical setting, as well as studying whether heating or cooling the drugs changes the effectiveness of treatment.
The study is being conducted at Brigham and Women’s Hospital in Boston, Massachusetts. For more information on the study, contact David Sugarbaker, M.D. or Tamara Tilleman, M.D, Ph.D.
Weitz & Luxenberg is a leading plaintiffs' law firm that has represented people affected by mesothelioma for over 20 years. Men and women diagnosed with mesothelioma caused by asbestos exposure may be entitled to compensation from the companies responsible for their disease.
If you would like a free consultation or more information about your legal options, please complete the form below, and a representative of our law firm will contact you as soon as possible.

Clinical research trial of experimental mesothelioma drug Dasatinib